Established in 2012, Sollfege Smart Electronics delivers integrated technology systems designed to upgrade residential and commercial properties. The company originally operated as a conventional audio and video equipment distributor before transitioning into a diversified technology solutions business. Today, its portfolio spans professional audio and video systems, home automation, smart living infrastructure, lifestyle electronics, and wellness applications, with a strategic focus on delivering high-end functionality and modern automation for contemporary living spaces.
Market Dashboard
Sollfege Smart Electronics
ListedSMEFixed Price Issue
Issue Price
₹55Face Value
₹10 Per Equity ShareIssue Size
Approx ₹21.78 CroresListing On
BSE SME
Live
Allotment Available
Check your individual allotment on the official registrar portal.
Grey Market
₹0
+0.00% Est. Listing Premium
Est. Listing Price₹55
Updated: 03 Oct 2026, 10:22
About Sollfege Smart Electronics IPO
Financial Health
Live Subscriptions
Tracking
Frequently Asked Questions
The public subscription window officially opens on 30 September 2026 and concludes at 5:00 PM IST on 05 October 2026.
As of the latest market information, the GMP is ₹0, indicating a 0.00% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹55. Retail investors must bid for at least 4000 shares, requiring a block investment of ₹2,20,000.
The allotment has been detected as available in the Kfin Technologies Ltd. system. You can use the official registrar link on this page to check your individual status. Shares are scheduled to debut on the exchanges on 08 October 2026.
The registrar for this IPO is Kfin Technologies Ltd..
The issue size for Sollfege Smart Electronics is Approx ₹21.78 Crores.
The current status of the Sollfege Smart Electronics IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.